United States · FDA National Drug Code directory
PROCHLORPERAZINE EDISYLATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43066-090_5894a965-dd6b-4435-b2e5-203a23d4b70e
- Product NDC
- 43066-090
- Form
- INJECTION
- Composition / generic term
- prochlorperazine edisylate
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210503
- Source listing expiry
- 20261231
Source-listed ingredients
- PROCHLORPERAZINE EDISYLATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (43066-090-25) / 2 mL in 1 VIAL (43066-090-01) · 43066-090-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →